PhD Scholarship in Gold-based Drugs for Effective Ovarian Cancer Treatment Australia 2022

RMIT University invites applications for the PhD Scholarship in Gold-based Drugs for effective Ovarian Cancer Treatment in Australia for the 2022/23 academic year.

This project will develop and test new gold-based compounds as alternatives to current ovarian cancer chemotherapies.

As a result, the scholarship will fund a 3 year PhD candidature to work in the Chemistry Department of the RMIT School of Science CAMIC Laboratory. This project is a collaboration with immunologists (SHBS) to test gold compounds as anti-ovarian cancer therapeutics.

Worth of Award

  • The value of the scholarship is equivalent to a standard RMIT Scholarship.
  • Undoubtedly, it will be available for up to 3 years with an extension to 3.5 years if required.
ALSO READ:   World Habitat Awards for Innovative Solutions on Housing Challenges 2022


  • Applicants need to have a background in synthetic organometallic chemistry using air-sensitive technologies and some interest in medicinal chemistry.
  • They must have completed a relevant Bachelor’s Degree and Honour’s or Master’s in synthetic inorganic chemistry/medicinal/pharmacology.
  • Due to COVID-19 restrictions, applicants living in Australia at the time of application will be preferred.

How to Apply 

Email Dr Ruchika Ojha and Distinguished Professor Suresh Bhargava ([email protected]) directly with your statement of interest, cover letter addressing the desirable criteria, CV and academic qualifications.

Deadline: Applications for the PhD Scholarship in Gold-based Drugs end on March 1st, 2022,


Click here for more details and to apply